Your session is about to expire
← Back to Search
N-Acetylcysteine for Substance Use Disorder (NAC_CUD-TUD Trial)
NAC_CUD-TUD Trial Summary
This trial will test whether NAC can reduce the amount of tobacco and cannabis people use.
NAC_CUD-TUD Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowNAC_CUD-TUD Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2024 Phase 2 trial • 13 Patients • NCT03499249NAC_CUD-TUD Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You must smoke regular cigarettes every day, without adding cannabis.I am taking bupropion for depression, not to quit smoking.I have been diagnosed with tobacco use disorder in the last year.I am not using non-study chemotherapy now or during the study.I have used cannabis in the last 30 days and tested positive for THC.I am a smoker, 18 or older, and have smoked regularly for the past month.I am of childbearing age and my pregnancy test is negative.I am using or will use medication to quit smoking during the study.You agree to receive help to quit smoking cigarettes and reduce your use of cannabis.In the past month, you have either tried to harm yourself or have had strong thoughts about wanting to harm yourself.
- Group 1: Placebo Comparator: Placebo & cognitive behavioral therapy
- Group 2: N-acetyl cysteine (NAC) & cognitive behavioral therapy
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there current openings for this clinical experiment?
"Affirmative, the information available on clinicaltrials.gov conveys that this trial is actively recruiting volunteers. This research project was initially published 8/25/2021 and had its most recent update 9/26/2022. Sixty participants are desired from a single site."
What is the current total of participants enrolled in this medical experiment?
"Affirmative. According to information found on clinicaltrials.gov, this study is presently seeking participants with the initial post dated August 25th 2021 and last revised September 26th 2022. The trial will require 60 individuals from a single medical centre for completion."
What level of safety has been observed with the therapeutic use of N-Acetyl cysteine?
"Because N-Acetyl cysteine has already been approved, its safety rating is a 3 according to our assessment."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Typically responds via
Share this study with friends
Copy Link
Messenger